Epigenetic Mechanisms Underlying the Pathogenesis of Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML)

被引：0
|
作者：
Cheng, J. X.
Anastasi, J.
Shen, J. Q.
Watanabe, K.
Grimley, E.
Kleinbrink, E.
Knibbs, R.
Roulston, D.
Vardiman, J. W.
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Univ Chicago, Chicago, IL 60637 USA
[3] Univ Nevada, Las Vegas, NV 89154 USA
来源：
LABORATORY INVESTIGATION | 2012年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1382
引用
收藏
页码：329A / 330A
页数：2
相关论文
共 50 条
  • [31] PREDICTIVE FACTORS FOR EVOLUTION FROM OLIGOMONOCYTIC CHRONIC MYELOMONOCYTIC LEUKEMIA (OM-CMML) TO CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
    Bravo David, Roman
    Rocha Leonor, Arenillas
    Maria Teresa, Asensi
    Nieves, Garcia-Gisbert
    Juan Jose, Rodriguez Sevilla
    Ruiz Brayan, Merchan
    Avila Sara, Garcia
    Paricio Beatriz, Bellosillo
    Maria Concepcion, Fernandez-Rodriguez
    Brichs Lourdes, Florensa
    del Alamo Ana, Ferrer
    Gonzalez Xavier, Calvo
    HAEMATOLOGICA, 2021, 106 (10) : 252 - 252
  • [32] Diagnostic utility of mast cell tryptase immunostaining in bone marrow core biopsies in myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML)
    Zeng, G
    An, C
    Nishino, H
    Zu, Y
    Saleem, A
    Ewton, A
    Chang, C
    LABORATORY INVESTIGATION, 2005, 85 : 260A - 260A
  • [33] IMPACT OF MARROW COMPLETE RESPONSE IN THE NATURAL HISTORY OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) AND CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) TREATED WITH HYPOMETHYLATING AGENTS
    Pierola, A. Alfonso
    Montalban-Bravo, G.
    Takahashi, K.
    Jabbour, E. J.
    Kadia, T.
    Ravandi, F.
    Cortes, J.
    DiNardo, C.
    Daver, N.
    Borthakur, G.
    Pemmaraju, N.
    Konopleva, M.
    Bueso-Ramos, C.
    Pierce, S.
    Kantarjian, H.
    Garcia-Manero, G.
    HAEMATOLOGICA, 2017, 102 : 263 - 264
  • [34] Diagnostic utility of mast cell tryptase immunostaining in bone marrow core biopsies in myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML)
    Zeng, G
    An, C
    Nishino, H
    Zu, Y
    Saleem, A
    Ewton, A
    Chang, C
    MODERN PATHOLOGY, 2005, 18 : 260A - 260A
  • [35] PREDICTIVE FACTORS OF OLIGOMONOCYTIC CHRONIC MYELOMONOCYTIC LEUKEMIA (OM-CMML) EVOLUTION TO OVERT CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
    Roman, D.
    Arenillas, L.
    Asensi, M. T.
    Garcia-Gisbert, N.
    Rodriguez, J. J.
    Merchan, B.
    Garcia, S.
    Bellosillo, B.
    Fernandez, M. C.
    Florensa, L.
    Ferrer, A.
    Calvo, X.
    LEUKEMIA RESEARCH, 2021, 108 : S14 - S14
  • [36] Chronic inflammatory demyelinating polyneuropathy accompanied by chronic myelomonocytic leukemia: possible pathogenesis of autoimmunity in myelodysplastic syndrome
    Isoda, Atsushi
    Sakurai, Atsushi
    Ogawa, Yoshiyuki
    Miyazawa, Yuri
    Saito, Akio
    Matsumoto, Morio
    Sawamura, Morio
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2009, 90 (02) : 239 - 242
  • [37] Chronic inflammatory demyelinating polyneuropathy accompanied by chronic myelomonocytic leukemia: possible pathogenesis of autoimmunity in myelodysplastic syndrome
    Atsushi Isoda
    Atsushi Sakurai
    Yoshiyuki Ogawa
    Yuri Miyazawa
    Akio Saito
    Morio Matsumoto
    Morio Sawamura
    International Journal of Hematology, 2009, 90 : 239 - 242
  • [38] On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia
    Feldman, E. J.
    Cortes, J.
    DeAngelo, D. J.
    Holyoake, T.
    Simonsson, B.
    O'Brien, S. G.
    Reiffers, J.
    Turner, A. R.
    Roboz, G. J.
    Lipton, J. H.
    Maloisel, F.
    Colombat, P.
    Martinelli, G.
    Nielsen, J. L.
    Petersdorf, S.
    Guilhot, F.
    Barker, J.
    Kirschmeier, P.
    Frank, E.
    Statkevich, P.
    Zhu, Y.
    Loechner, S.
    List, A.
    LEUKEMIA, 2008, 22 (09) : 1707 - 1711
  • [39] On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia
    E J Feldman
    J Cortes
    D J DeAngelo
    T Holyoake
    B Simonsson
    S G O'Brien
    J Reiffers
    A R Turner
    G J Roboz
    J H Lipton
    F Maloisel
    P Colombat
    G Martinelli
    J L Nielsen
    S Petersdorf
    F Guilhot
    J Barker
    P Kirschmeier
    E Frank
    P Statkevich
    Y Zhu
    S Loechner
    A List
    Leukemia, 2008, 22 : 1707 - 1711
  • [40] CHRONIC MYELOMONOCYTIC LEUKEMIA (CMMOL) PLUS THE MYELODYSPLASTIC SYNDROME
    WICKRAMANAYAKE, PD
    PALLENSCHAT, J
    DIEHL, V
    MEDIZINISCHE KLINIK, 1991, 86 (08) : 383 - 386
12345